Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » The Role of Signaling Pathways in Painful Diabetic Neuropathy
Disease Discoveries

The Role of Signaling Pathways in Painful Diabetic Neuropathy

By Sarah PlumridgeJul 18, 2014
Share
Facebook Twitter Email
Electrophysiological studies show the effect of chemokine signaling in sensory neurons. This image illustrates an increase in excitability of neurons when in the presence of those proteins. 

 

Painful Diabetic Neuropathy (PDN), a disorder that causes severe nerve damage throughout the body, affects more than a quarter of diabetes patients.

Daniela Menichella, MD, PhD, assistant professor in Neurology, has established that a specific signaling pathway may lead to the excitability of sensory neurons and inflammation in PDN. The sustained excitability of these neurons reduces the pain threshold of those with the disease.

“We do not fully understand the molecular mechanisms that underlie neuropathic pain in diabetes and we are trying to learn why the sensory neurons that signal pain are expressing higher excitability,” Dr. Menichella said. “In patients with PDN, the pain threshold is lower than in healthy individuals and current therapies are only partially effective.”

Sensory neurons display excitability in response to different molecules, including chemokines, or signaling proteins. Combining pain behavioral tests, electrophysiology studies, in vitro and in vivo calcium imaging studies, and transgenic mouse models, Dr. Menichella identified chemokine SDF-1 and its receptor CXCR4 as pivotal in the development of PDN.

Part of these research findings have been recently published in Molecular Pain.

Daniela Menichella, MD, PhD, assistant professor in Neurology, demonstrated that chemokine signaling is responsible for the excitability of sensory neurons and inflammation in Painful Diabetic Neuropathy.

“These findings open up a completely new field of molecular investigation in this disease,” she said. “Now that we have identified a possible signaling pathway for the disease, we can create a targeted therapy. By modifying the neurobiology and controlling inflammation, we can not only treat the pain but also slow the progression of the disease.”

Through her investigations, Dr. Menichella also observed that expression of the receptor CXCR4 caused inflammatory cells to go into the sensory neurons.

She now investigates the communication between this excitability in sensory neurons and inflammation.

“As a neurologist, I see patients with PDN and it has a very high impact on the quality of life of the patient. Finding the molecular mechanism, we can develop a targeted therapy and then translate it to patients,” said Dr. Menichella. “Neuropathic pain is found in rheumatologic conditions and hereditary, amyloid and chemotherapy-induced neuropathies. So knowing how inflammation and chemokines control excitability in sensory neurons is a concept that can be applied to other diseases.”

The study is funded by National Institute of Neurological Disorders and Stroke grant K08NS079482.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.